CRISPR-Cas9-mediated disruption of B2M and CIITA genes eliminates HLA class I and II expression in human induced pluripotent stem cells (MUSIi001-A-2)

Cell-based therapy offers great promise for treating degenerative diseases. Although autologous cell-based therapy is ideal, it may be impractical due to the high manufacturing cost and long production time. Allogeneic cell-based therapy offers a more cost-effective alternative; however, the risk of...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Nontaphat Thongsin, Siriwal Suwanpitak, Methichit Wattanapanitch
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Elsevier 2023-09-01
Loạt:Stem Cell Research
Truy cập trực tuyến:http://www.sciencedirect.com/science/article/pii/S1873506123001241